Diverse etiologies, diagnostic approach, and management of primary adrenal insufficiency in pediatric age

Primary adrenal insufficiency (PAI) in pediatric age is a rare, but potentially fatal condition caused by diverse etiologies including biochemical defects of steroid biosynthesis, developmental abnormalities of the adrenal gland, or reduced responsiveness to adrenocorticotropic hormone. Compared to adult PAI, pediatric PAI is more often the result of genetic (monogenic, syndromic disorders) than acquired conditions. During the past decade, rare monogenic disorders associated with PAI have helped unravel the underlying novel molecular genetic mechanism. The diagnosis of adrenal insufficiency in children and young infancy is often challenging, usually based on clinical suspicion and endocrine laboratory findings. Pediatric endocrinologists sometimes encounter therapeutic difficulty in finding the balance between undertreatment and overtreatment, determining how to optimize the dose over the patient’s lifetime, and maximizing mimicry of normal cortisol secretion with glucocorticoid replacement therapy.

[1]  F. Barzaghi,et al.  IPEX Syndrome: Improved Knowledge of Immune Pathogenesis Empowers Diagnosis , 2021, Frontiers in Pediatrics.

[2]  I. del Valle,et al.  Current Insights Into Adrenal Insufficiency in the Newborn and Young Infant , 2020, Frontiers in Pediatrics.

[3]  M. Maghnie,et al.  Primary Adrenal Insufficiency in childhood: data from a large nationwide cohort. , 2020, The Journal of clinical endocrinology and metabolism.

[4]  C. Cheon,et al.  Clinical, endocrinological, and molecular features of four Korean cases of cytochrome P450 oxidoreductase deficiency , 2020, Annals of pediatric endocrinology & metabolism.

[5]  J. Achermann,et al.  Primary adrenal insufficiency: New genetic causes and their long‐term consequences , 2019, Clinical endocrinology.

[6]  K. Watterberg,et al.  Effect of Prophylaxis for Early Adrenal Insufficiency Using Low-Dose Hydrocortisone in Very Preterm Infants: An Individual Patient Data Meta-Analysis. , 2019, The Journal of pediatrics.

[7]  A. Oprea,et al.  Novel insights into glucocorticoid replacement therapy for pediatric and adult adrenal insufficiency , 2019, Therapeutic advances in endocrinology and metabolism.

[8]  Youn-Jeong Choi,et al.  Sphingosine phosphate lyase insufficiency syndrome (SPLIS): A novel inborn error of sphingolipid metabolism. , 2019, Advances in biological regulation.

[9]  R. Dineen,et al.  Factors impacting on the action of glucocorticoids in patients receiving glucocorticoid therapy , 2018, Clinical endocrinology.

[10]  Lara Frommer,et al.  Autoimmune Polyendocrinopathy. , 2019, The Journal of clinical endocrinology and metabolism.

[11]  Martin A. M. Reijns,et al.  DNA Polymerase Epsilon Deficiency Causes IMAGe Syndrome with Variable Immunodeficiency , 2018, American journal of human genetics.

[12]  C. Stratakis,et al.  An overview of inborn errors of metabolism manifesting with primary adrenal insufficiency , 2018, Reviews in Endocrine and Metabolic Disorders.

[13]  J. Ko,et al.  A case of an infant suspected as IMAGE syndrome who were finally diagnosed with MIRAGE syndrome by targeted Mendelian exome sequencing , 2018, BMC Medical Genetics.

[14]  N. Zelinska Вроджена гіперплазія надниркових залоз внаслідок дефіциту 21-гідроксилази. Клінічні практичні настанови Ендокринологічного Товариства. Частина 1 , 2018 .

[15]  L. Metherell,et al.  Sphingosine-1-phosphate lyase mutations cause primary adrenal insufficiency and steroid-resistant nephrotic syndrome , 2017, The Journal of clinical investigation.

[16]  M. Dattani,et al.  Mitochondrial disease and endocrine dysfunction , 2017, Nature Reviews Endocrinology.

[17]  H. Yoo,et al.  Mutation Spectrum of STAR and the Founder Effect of p.Q258* in Korean Patients with Congenital Lipoid Adrenal Hyperplasia , 2017, Molecular Medicine.

[18]  H. Okano,et al.  SAMD9 mutations cause a novel multisystem disorder, MIRAGE syndrome, and are associated with loss of chromosome 7 , 2016, Nature Genetics.

[19]  M. Didi,et al.  The diagnosis and treatment of adrenal insufficiency during childhood and adolescence , 2016, Archives of Disease in Childhood.

[20]  Stefan R Bornstein,et al.  Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. , 2016, The Journal of clinical endocrinology and metabolism.

[21]  H. Yoo,et al.  Novel Heterozygous Mutations of NR5A1 and Their Functional Characteristics in Patients with 46,XY Disorders of Sex Development without Adrenal Insufficiency , 2015, Hormone Research in Paediatrics.

[22]  B. Poll-The,et al.  High prevalence of primary adrenal insufficiency in Zellweger spectrum disorders , 2014, Orphanet Journal of Rare Diseases.

[23]  C. Flück,et al.  Novel Insight into Etiology, Diagnosis and Management of Primary Adrenal Insufficiency , 2014, Hormone Research in Paediatrics.

[24]  L. Metherell,et al.  Thioredoxin Reductase 2 (TXNRD2) Mutation Associated With Familial Glucocorticoid Deficiency (FGD) , 2014, The Journal of clinical endocrinology and metabolism.

[25]  H. Yoo,et al.  A review of the literature on common CYP17A1 mutations in adults with 17-hydroxylase/17,20-lyase deficiency, a case series of such mutations among Koreans and functional characteristics of a novel mutation. , 2014, Metabolism: clinical and experimental.

[26]  P. Grenier,et al.  Primary adrenal insufficiency due to bilateral adrenal hemorrhage-adrenal infarction in the antiphospholipid syndrome: long-term outcome of 16 patients. , 2013, The Journal of clinical endocrinology and metabolism.

[27]  Claire Hughes,et al.  Familial glucocorticoid deficiency: New genes and mechanisms , 2013, Molecular and Cellular Endocrinology.

[28]  B. Poll-The,et al.  X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management , 2012, Orphanet Journal of Rare Diseases.

[29]  F. Wagner,et al.  Mutations in Nicotinamide Nucleotide Transhydrogenase (NNT) cause familial glucocorticoid deficiency , 2012, Nature Genetics.

[30]  J. Abdenur,et al.  Pearson syndrome: unique endocrine manifestations including neonatal diabetes and adrenal insufficiency. , 2012, Molecular genetics and metabolism.

[31]  S. Nelson,et al.  Mutations in the PCNA-binding domain of CDKN1C cause IMAGE Syndrome , 2012, Nature Genetics.

[32]  L. Metherell,et al.  MCM4 mutation causes adrenal failure, short stature, and natural killer cell deficiency in humans. , 2012, The Journal of clinical investigation.

[33]  J. Ko,et al.  Clinical phenotype and mutation spectrum of the CYP21A2 gene in patients with steroid 21-hydroxylase deficiency. , 2012, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[34]  Ji Eun Lee,et al.  High allele frequency of the p.Q258X mutation and identification of a novel mis-splicing mutation in the STAR gene in Korean patients with congenital lipoid adrenal hyperplasia. , 2011, European journal of endocrinology.

[35]  D. Berney,et al.  Nonclassic lipoid congenital adrenal hyperplasia masquerading as familial glucocorticoid deficiency. , 2009, The Journal of clinical endocrinology and metabolism.

[36]  T. Webb,et al.  The majority of adrenocorticotropin receptor (melanocortin 2 receptor) mutations found in familial glucocorticoid deficiency type 1 lead to defective trafficking of the receptor to the cell surface. , 2008, The Journal of clinical endocrinology and metabolism.

[37]  H. Yoo,et al.  Identification of Novel Mutations of the DAX-1 Gene in Patients with X-Linked Adrenal Hypoplasia Congenita , 2005, Hormone Research in Paediatrics.

[38]  F. Rüschendorf,et al.  Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2 , 2005, Nature Genetics.

[39]  M. Nowaczyk,et al.  Adrenal insufficiency and hypertension in a newborn infant with Smith-Lemli-Opitz syndrome. , 2001, American journal of medical genetics.

[40]  G. Bryson,et al.  Lysosomal acid lipase mutations that determine phenotype in Wolman and cholesterol ester storage disease. , 1999, Molecular genetics and metabolism.

[41]  G. Clayden,et al.  FAMILIAL GLUCOCORTICOID DEFICIENCY WITH ACHALASIA OF THE CARDIA AND DEFICIENT TEAR PRODUCTION , 1978, The Lancet.